OP-ED: FUNDING ROADBLOCKS CREATING DIGITAL HEALTH INEQUITY Beyond just clinical: Making the case for a pivot in reimbursement by Australian Government
With
Helen Souris,
CEO and Executive Director
Cardihab &
Board Member
Medical Technology Association of Australia (MTAA)
OP ED SEGMENT
Filmed in Sydney | June 2026
Helen Souris, CEO and Executive Director of Cardihab and Chair of the Digital Health Advisory Group at the Medical Technology Association of Australia (MTAA), highlights the significant gap in cardiac rehabilitation access across Australia. Despite the proven benefits of cardiac rehabilitation in improving survival, quality of life, and reducing hospital admissions, around 80% of eligible patients do not receive this care, with access rates even lower in regional and rural communities.
Cardihab was established as a digital health company originating from CSIRO research and has spent the past decade developing a digital therapeutic solution for cardiac rehabilitation.
Delivered through a clinically supervised software platform, the program enables patients to access rehabilitation remotely, removing barriers associated with travel and face-to-face attendance. The platform is registered with the Therapeutic Goods Administration (TGA) as a Class IIa medical device, reflecting its compliance with rigorous clinical and regulatory standards.
Over ten years, Cardihab has built a substantial evidence base, including randomised controlled trials and real-world studies. Independent research has demonstrated improvements in patient outcomes, quality of life, and cost-effectiveness, with the program outperforming traditional alternatives in most evaluated scenarios. As a result, the majority of private health insurers now support access to the platform, while statewide implementation has been achieved through partnerships such as the Tasmanian Health Service.
Despite these successes, Souris identifies funding as the primary barrier to broader adoption within the public health system. She argues that Australia already possesses the technology required to support the government’s digital health ambitions and that sustainable funding and reimbursement mechanisms are now needed to enable widespread access to evidence-based digital therapeutics and remote patient care solutions.
Source: Adapted from transcript
Media access credit: Medical Technology Association of Australia (MTAA)
Note: Op Ed segments are opinions and comments on policies. They should be watched for awareness purposes only, and do not necessarily reflect the views held by Australian Health Journal.
-
Smart technology in wound care
Throughout her journey around wound care, Santosh Kaur was frustrated to see the simple gaps in wound care resulting in negative patient outcomes. Santosh is the founder of SmartHeal which launched in 2020.
SmartHeal replaces the nurses taking cumbersome manual measurements and manual sharing of important wound data with a no touch technique. It aims for healthcare professionals to have live remote access to wound data, make wound assessments and assist with speech to text notes thus saving time, cost and people. SmartHeal also aims to assist healthcare professionals in providing optimum wound care by analysing the wound tissue for infection, moisture and providing suggestions for suitable dressing.
-
CASE STUDY: Creating awareness, workforce education & dissemination strategy in national screening
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
-
Developing the nation’s first Health and Medical Research Strategy
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
